Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Lower Extremity Pressure Splints in HP

NCT: NCT06965894 · COMPLETED

NCT IDNCT06965894
StatusCOMPLETED
Start Date2025-05-13
Completion2025-11-25
SponsorIstinye University (OTHER)
First posted
Last updated

Brief Summary

Hemiplegia (weakness or paralysis on one side of the body) often impacts the lower extremities, making it challenging for patients to walk or move their legs effectively. This study aims to explore the effects of pressure splints on the lower extremity movement and function in individuals who have experienced a stroke and suffer from hemiplegia. Pressure splints are specialized devices designed to support and enhance muscle function by applying gentle pressure to the affected limbs. Participants in this study will be randomly assigned to one of two groups: the Splint Group (SG) or the Control Group (CG). The duration of the intervention will be six weeks. During this period, all the participants will receive neurodevelopmental therapy. In the SG exercises will be done with the help of the lower extremity pressure splints while participants in the CG will join the exercises without any splint. This study is significant as it may lead to the development of new methods to enhance recovery for stroke patients and offer better rehabilitation options.

Frequently Asked Questions

What is Lower Extremity Pressure Splints in HP?

Lower Extremity Pressure Splints in HP is a clinical trial registered under NCT06965894. Current status: COMPLETED.

What is the status of NCT06965894?

The current status of NCT06965894 (Lower Extremity Pressure Splints in HP) is: COMPLETED.

When did Lower Extremity Pressure Splints in HP start?

Lower Extremity Pressure Splints in HP started on 2025-05-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.